Target cells for immunomodulatory action of muramyl dipeptide.

I. M. Dozmorov, L. V. Bagaeva, I. I. Kuzin, E. V. Svirshchevskaya

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Identification of the target cells for the immunomodulatory action of muramyl dipeptide (MDP) was addressed by investigation of various B-cell and T-cell lines. The lines used were: IM-9, a human lymphoblastoid B-cell line that spontaneously produces IgG; EL-4, a murine T-cell line that produces interleukin-2 (IL-2) on stimulation with phorbol myristate acetate; and CTLL-2, an IL-2-dependent murine T-cell line. MDP was shown to modulate such T-cell and B-cell functions as cell proliferation and secretion of IL-2 and IgG, respectively, in vitro. The effect of MDP in vitro was determined by both MDP dose and the control level of cell activity. The evidence obtained supports the possibility of the direct action of MDP on T and B lymphocytes.

Original languageEnglish (US)
Pages (from-to)193-197
Number of pages5
JournalBiomedical science
Volume2
Issue number2
StatePublished - 1991

Fingerprint Dive into the research topics of 'Target cells for immunomodulatory action of muramyl dipeptide.'. Together they form a unique fingerprint.

  • Cite this

    Dozmorov, I. M., Bagaeva, L. V., Kuzin, I. I., & Svirshchevskaya, E. V. (1991). Target cells for immunomodulatory action of muramyl dipeptide. Biomedical science, 2(2), 193-197.